HCA Stock Recent News

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for HCA (HCA), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2025.

I believe HCA Healthcare is currently undervalued, especially after a recent 20.9% share price drop, making it a compelling 'buy' candidate. HCA Healthcare's financial performance has been solid, with revenue rising 5.7% year-over-year, driven by increased hospital traffic and higher revenue per admission. Despite mixed profitability metrics, management's forecast for 2025 shows expected revenue growth and higher profits, reinforcing my bullish stance.

NASHVILLE, Tenn. & ORANGE, Calif. & BOSTON--(BUSINESS WIRE)--Two large multi-state studies funded by the National Institutes of Health and led by the University of California, Irvine, Harvard Pilgrim Health Care Institute, and HCA Healthcare have found a highly effective method to improve antibiotic selection for patients who are hospitalized with abdominal or skin and soft tissue infection to reduce their risk of antibiotic resistance. Results were published in JAMA Surgery and JAMA Internal M.

The March 2025 US jobs report revealed a robust addition of 228,000 jobs, surpassing economists' expectations of 140,000 and the 12-month average of 158,000.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Five defensive stocks to buy at this soaring volatility are TAP, CNP, WEC, BSX, HCA.

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that it has been named on Fortune's 2025 World's Most Admired Companies list. HCA Healthcare is ranked first overall in its industry. “It is an honor to be named a World's Most Admired Company by Fortune again this year,” said Sam Hazen, CEO of HCA Healthcare. “Recognition on this list underscores our unwavering dedication to our colleagues and patients as we con.

Is a recession coming? Our economic outlook seems increasingly gloomy due to President Trump's trade policies.

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast: What: HCA Healthcare, Inc. 1Q 2025 Earnings Call When: Friday, April 25, 2025 at 9:00 AM Central (10:00 AM Eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, frank.morgan@hcahealthcare.com If you are unable to listen during the live webcast, the call will be.

HCA Healthcare shares have gained 5% over the past year, with potential Medicaid cuts posing a modest future risk to revenue. Despite potential Medicaid cuts, HCA's relatively low Medicaid exposure (11% of revenue) limits the impact to about 0.5% of revenue. HCA's strong financial performance, including $5.6 billion in free cash flow and robust buybacks, supports ongoing capital returns to investors.